Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Avastin versus best available therapy for CNV secondary to age-related macular degeneration
2006-001544-31Phase 4Completed
- Sponsor
- Moorfields Eye Hospital
- Start
- May 2006
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of bevacizumab in age-related macular degeneration (AMD) (2 arms), sponsored by Moorfields Eye Hospital. Started May 2006; status: completed.
02
Drugs
bevacizumab
03
Conditions
age-related macular degeneration (AMD)
Beyond the preview
Go deeper on 2006-001544-31.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-001544-31.